Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Net Asset Momentum
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) recorded a net asset momentum of 18.1% as of December 2024, with net assets of CN¥7.85 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Tianjin Zhongxin Pharmaceutical Group Co for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Net Asset Momentum (1998–2024)
This chart tracks Tianjin Zhongxin Pharmaceutical Group Corp Ltd's year-over-year net asset growth across 27 annual reporting periods from 1998 to 2024. The most recent momentum reading is +18.1%, with net assets of CN¥7.85 Billion CNY as of December 2024. For live market cap and overall valuation, see Tianjin Zhongxin Pharmaceutical Group Co (600329) market capitalisation.
Annual Net Asset History for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (1998–2024)
The table below shows the complete annual net asset history for Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 1998 to 2024, covering 27 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Tianjin Zhongxin Pharmaceutical Group Co tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥7.85 Billion | CN¥10.77 Billion | CN¥2.92 Billion | ▲ +18.1% |
| 2023 | CN¥6.65 Billion | CN¥10.23 Billion | CN¥3.58 Billion | ▲ +1.4% |
| 2022 | CN¥6.55 Billion | CN¥10.16 Billion | CN¥3.61 Billion | ▲ +0.6% |
| 2021 | CN¥6.51 Billion | CN¥9.07 Billion | CN¥2.55 Billion | ▲ +9.5% |
| 2020 | CN¥5.95 Billion | CN¥8.28 Billion | CN¥2.33 Billion | ▲ +7.7% |
| 2019 | CN¥5.52 Billion | CN¥7.84 Billion | CN¥2.32 Billion | ▲ +9.3% |
| 2018 | CN¥5.05 Billion | CN¥7.11 Billion | CN¥2.05 Billion | ▲ +9.3% |
| 2017 | CN¥4.63 Billion | CN¥6.62 Billion | CN¥2.00 Billion | ▲ +7.5% |
| 2016 | CN¥4.30 Billion | CN¥6.36 Billion | CN¥2.06 Billion | ▲ +4.8% |
| 2015 | CN¥4.11 Billion | CN¥6.07 Billion | CN¥1.96 Billion | ▲ +39.3% |
| 2014 | CN¥2.95 Billion | CN¥5.44 Billion | CN¥2.49 Billion | ▲ +14.4% |
| 2013 | CN¥2.57 Billion | CN¥5.26 Billion | CN¥2.69 Billion | ▲ +13.0% |
| 2012 | CN¥2.28 Billion | CN¥4.42 Billion | CN¥2.14 Billion | ▲ +3.3% |
| 2011 | CN¥2.21 Billion | CN¥4.14 Billion | CN¥1.94 Billion | ▲ +5.7% |
| 2010 | CN¥2.09 Billion | CN¥3.84 Billion | CN¥1.75 Billion | ▲ +16.7% |
| 2009 | CN¥1.79 Billion | CN¥3.67 Billion | CN¥1.88 Billion | ▲ +21.4% |
| 2008 | CN¥1.47 Billion | CN¥3.44 Billion | CN¥1.97 Billion | ▲ +9.5% |
| 2007 | CN¥1.35 Billion | CN¥3.47 Billion | CN¥2.13 Billion | ▼ -4.5% |
| 2006 | CN¥1.41 Billion | CN¥3.51 Billion | CN¥2.10 Billion | ▼ -27.7% |
| 2005 | CN¥1.95 Billion | CN¥4.06 Billion | CN¥2.11 Billion | ▲ +3.8% |
| 2004 | CN¥1.88 Billion | CN¥3.91 Billion | CN¥2.04 Billion | ▲ +2.1% |
| 2003 | CN¥1.84 Billion | CN¥3.80 Billion | CN¥1.96 Billion | ▲ +8.9% |
| 2002 | CN¥1.69 Billion | CN¥3.01 Billion | CN¥1.32 Billion | ▲ +9.6% |
| 2001 | CN¥1.54 Billion | CN¥2.72 Billion | CN¥1.18 Billion | ▲ +33.9% |
| 2000 | CN¥1.15 Billion | CN¥2.53 Billion | CN¥1.38 Billion | ▲ +0.8% |
| 1999 | CN¥1.14 Billion | CN¥1.45 Billion | CN¥306.96 Million | ▲ +7.9% |
| 1998 | CN¥1.06 Billion | CN¥1.28 Billion | CN¥220.53 Million | — |